Slide 1: Second Quarter 2013 Earnings Release
Exhibit 99.1 IDEX PROPRIETARY & CONFIDENTIAL Second Quarter 2013 Earnings Release July 23, 2013
Slide 2: Agenda
Agenda 2 IDEX Outlook Q2 Financial Performance Q2 Segment Performance Fluid & Metering Health & Science Fire & Safety / Diversified Guidance Update Q&A IDEX PROPRIETARY & CONFIDENTIAL
Slide 3: Replay Information
Replay Information 3 • Dial toll–free: 855.859.2056 • International: 404.537.3406 • Conference ID: #26074056 • Log on to: www.idexcorp.com IDEX PROPRIETARY & CONFIDENTIAL
Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act
4 Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward- looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause th
Slide 5: IDEX Q2 Financial Performance
IDEX Q2 Financial Performance 5 Revenue EPS* Organic: 2% growth 13% growth Operating Margin* Free Cash Flow 70 bps expansion 46% growth * Q2 2012 EPS/ OperatingMargin data adjusted for restructuring expenses($2.6M) Outstanding EPS, Margin & FCF performance IDEX PROPRIETARY & CONFIDENTIAL
Slide 6: Fluid & Metering
Fluid & Metering 6 Orders Revenue Operating Margin* Organic: 10% growth Organic: 7% growth 280 bps expansion Q2 Sales Mix:Organic 7% Q2 Summary: Excellent improvement in organic orders and revenue, driven by Acquisition 0% strength in Energy and Ag Operating margin improved 280 bps on volume strengt
Slide 7: Health & Science
Health & Science 7 Orders Revenue Operating Margin* Organic: 1% growth Organic: 2% decline 250 bps expansion Q2 Sales Mix:Organic -2% Q2 Summary: Organic sales declined year-over-year, but grew 2 percent sequentially Acquisition 9% Operating margins expanded 250 basis points on the strength of focus
Slide 8: Fire & Safety/Diversified
Fire & Safety/Diversified 8 Orders Revenue Operating Margin* Organic: 3% growth Organic: 1% decline 270 bps decline Q2 Sales Mix:Organic -1% Q2 Summary: Strong organic order growth contributions from FSG and Dispensing Acquisition 0% Op margin decline due to a charge associated with a facility closu
Slide 9: Outlook: 2013 Guidance Summary
Outlook: 2013 Guidance Summary 9 Q3 2013 • EPS estimate range: $0.72 – $0.74 • Organic revenue growth ~ 3 – 4% • Positive revenue impact from acquisition of ~ 2% • Operating margin ~ 19% FY 2013 • EPS estimate range: $2.93 – $2.98 – Organic revenue growth ~ 3% – Positive revenue impact from acquisit
Slide 10: Q&A
10 Q&A IDEX PROPRIETARY & CONFIDENTIAL